Nwam LLC Grows Position in UnitedHealth Group Incorporated (NYSE:UNH)

Nwam LLC increased its position in UnitedHealth Group Incorporated (NYSE:UNH) by 4.5% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 4,386 shares of the healthcare conglomerate’s stock after purchasing an additional 188 shares during the quarter. Nwam LLC’s holdings in UnitedHealth Group were worth $2,219,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also added to or reduced their stakes in UNH. AlphaMark Advisors LLC purchased a new position in UnitedHealth Group during the fourth quarter valued at $30,000. RPg Family Wealth Advisory LLC purchased a new position in UnitedHealth Group during the third quarter valued at $37,000. DecisionPoint Financial LLC raised its stake in UnitedHealth Group by 155.0% during the fourth quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate’s stock valued at $52,000 after buying an additional 62 shares during the last quarter. Highline Wealth Partners LLC purchased a new position in UnitedHealth Group during the third quarter valued at $55,000. Finally, Legacy Investment Solutions LLC purchased a new position in shares of UnitedHealth Group in the third quarter worth $57,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Insider Activity at UnitedHealth Group

In related news, Director Timothy Patrick Flynn acquired 1,000 shares of the stock in a transaction dated Friday, January 17th. The stock was acquired at an average cost of $511.57 per share, with a total value of $511,570.00. Following the purchase, the director now directly owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. 0.33% of the stock is owned by corporate insiders.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $469.11 on Friday. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The stock has a 50-day moving average price of $517.10 and a 200 day moving average price of $557.79. The stock has a market capitalization of $431.71 billion, a P/E ratio of 30.26, a P/E/G ratio of 1.37 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. During the same quarter last year, the business posted $5.83 earnings per share. The firm’s revenue was up 6.8% on a year-over-year basis. Equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 18th. Investors of record on Monday, March 10th will be paid a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.79%. The ex-dividend date of this dividend is Monday, March 10th. UnitedHealth Group’s payout ratio is presently 54.19%.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on the company. Cantor Fitzgerald restated an “overweight” rating and issued a $700.00 price target on shares of UnitedHealth Group in a research note on Friday, January 17th. Hsbc Global Res raised UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. HSBC upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price objective for the company in a research report on Friday, January 10th. Truist Financial reduced their price objective on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research report on Monday, January 6th. Finally, KeyCorp reiterated an “overweight” rating and set a $650.00 price objective on shares of UnitedHealth Group in a research report on Friday, January 17th. One equities research analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and an average price target of $629.32.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.